Forian Exec Chairman Max C Wygod Acquires 15,867 Shares for $42,249

Max C Wygod, Exec Chairman, CEO, and President of Forian, acquired 15,867 shares for $42,249 across three transactions on February 11th, 12th, and 13th, 2025. The purchases were made at weighted average prices ranging from $2.52 to $2.87. Following the transactions, Wygod directly owns 1,328,047 shares of Forian.

Max C. Wygod, the Executive Chairman, CEO, and President of Forian, recently acquired a significant number of shares in the company, reflecting his confidence in its future growth prospects. According to insider trading data from CapEdge, Wygod purchased a total of 15,867 shares across three transactions on February 11th, 12th, and 13th, 2025 [1]. The purchases were made at weighted average prices ranging from $2.52 to $2.87.

Wygod's recent acquisitions bring his direct ownership of Forian shares to 1,328,047, representing a substantial increase from his previous holdings [1]. This purchase is not surprising, given Wygod's extensive experience as a healthcare executive and investor. As per his profile on The Org, Wygod has spent years investing, acquiring, and divesting public and private growth companies at the intersection of healthcare and information technology [2].

Moreover, Wygod's father, Marty Wygod, has a successful track record in the industry, having led seven public companies with an aggregate value of over $15 billion to public investors [2]. Marty's expertise in providing strategic direction to differentiate companies from their competitors and enhance their value in the public markets culminated in the sale of WebMD to a KKR portfolio company for $2.8 billion [2].

Wygod's recent acquisition of Forian shares is likely driven by his belief in the company's growth potential. Forian is a leading provider of healthcare data analytics and insights, and its solutions are used by healthcare providers, payers, and life sciences companies to improve patient outcomes, reduce costs, and enhance operational efficiency [3]. The company's revenue has grown steadily over the past few years, and it is well-positioned to benefit from the increasing demand for healthcare data analytics in the wake of the COVID-19 pandemic [3].

In conclusion, Max Wygod's recent acquisition of a significant number of shares in Forian is a testament to his confidence in the company's growth prospects. With his extensive experience in the healthcare industry and his father's successful track record, Wygod is well-positioned to provide strategic direction and enhance Forian's value in the public markets.

References:

[1] CapEdge. (2025, February 14). Max C. Wygod. https://capedge.com/person/1847923/max-c-wygod

[2] The Org. (n.d.). Max Wygod. https://theorg.com/org/forian/org-chart/max-wygod

[3] Forian. (n.d.). About Us. https://www.forian.com/about/